Tag:
Icon
Latest Headlines
Latest Headlines
Eying Big Pharma needs, Icon explains clinical tech buyout
Under pressure to improve efficiency of drug trials for Big Pharma clients like Pfizer, Ireland-based Icon is beefing up its clinical tech offerings and pushing to set itself apart from other CROs.
CRO Icon scoops up eClinical firm Firecrest
It's another CRO-eClinical marriage. Contract research giant Icon ($ICLR) said it has acquired Firecrest Clinical, which provides web-based tools for improving clinical trials site performance and
New Icon pact expands biomarker offerings
Icon has gained several new technologies from Proteome Sciences to help it bolster the biomarker work it does for drug developers. "This complements Icon's extensive portfolio of biomarker
